Form 4: Avalo Therapeutics CEO Neil Garry Arthur Reports Stock Transactions
SEC Form 4 Filing
CEO Neil Garry Arthur of Avalo Therapeutics reports the vesting and conversion of restricted stock units into common stock, along with a disposition of shares to cover tax obligations.
Summary
- On March 28, 2025, Neil Garry Arthur, the CEO of Avalo Therapeutics, had 64,867 restricted stock units vest and convert into common stock.
- Concurrently, Arthur disposed of 17,787 shares of common stock at a price of $8.46 to satisfy tax withholding obligations.
- Following these transactions, Arthur directly owns 47,140 shares of common stock and 129,733 restricted stock units.
- The restricted stock units were granted on August 13, 2024, and vest in three equal installments on March 28, 2025, March 28, 2026, and March 28, 2027, contingent upon continued service.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions by a company executive. It doesn't inherently indicate positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment with company performance.
Stakeholder Impact
- Shareholders may monitor these transactions to understand executive compensation and alignment with company goals.
Key Dates
| Date | Description |
|---|---|
| 08/13/2024 | Reporting Person was granted 194,600 restricted stock units |
| 03/28/2025 | Date of earliest transaction; 64,867 restricted stock units vested and converted; 17,787 shares disposed of for tax obligations |
| 03/28/2026 | Next vesting date for restricted stock units (1/3 of original grant) |
| 03/28/2027 | Final vesting date for restricted stock units (1/3 of original grant) |
| 04/01/2025 | Date of Form 4 filing |
Keywords
Avalo Therapeutics, Neil Garry Arthur, Form 4, Stock Transaction, Restricted Stock Units, Common Stock, Vesting, Tax Obligations, AVTX
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.